Nonalcoholic fatty liver disease in patients with type 2 diabetes

Abstract

The problem of NAFLD has been a matter of great interest among gastroenterologists, as well as endocrinologists and cardiologists. NAFLD is currently considered a component of hepatic metabolic syndrome. Understanding the multifactorial nature of NAFLD and the mechanisms of the associated diseases helps to adequately assess the prognosis of the disease and prescribe appropriate treatment.

Keywords

• неалкогольная жировая болезнь печени
• сахарный диабет 2-го типа
• фармакотерапия
• метформин
• non-alcoholic fatty liver disease
• type 2 diabetes
• drug therapy
• metformin